INTRODUCTION
With the identification of deficient enzymes (1) and improved methods of glycosphingolipid analysis (2) , knowledge of the hereditary glycosphingolipidoses has advanced profoundly in recent years. Improved diagnostic methods for these diseases have been developed. These techniques have included assay of enzyme deficiency in leukocytes, cultured fibroblasts, plasma, and amniotic fluid (3) . One ofthe major characteristics ofthe glycosphingolipidoses is the accumulation of glycosphingolipids in various tissues. Analysis of accumulated glycosphingolipids has proved very effective in diagnosis (4) . In addition, it has been proposed that analysis of glycosphingolipids in the urinary sediment can be a usefuil adjunct in the diagnosis of a wide variety of glycosphingolipidoses including: Krabbe's leukodystrophy, Gaucher's, Fabry's, Sandhoff's diseases, and metachromatic leukodystrophy (5) . Analysis of urinary sediment for trihexosylceramide and digalactosylceramide has been used to screen for hemizygotes and heterozygotes with Fabry's disease (5) (6) (7) (8) (9) (10) (11) (12) 
METHODS
Voided urine samples were collected at 4°C at 12 h intervals and were centriflged at 6,000 g for 30 min in a Sorval RC-2B refrigerated centrifuge (Ivan Sorvall, Inc., Norwalk, Conn.) using a GS-3 large capacity rotor. The sediment was collected. The pH of the supernate was then adjusted to 7.0. The supernate was concentrated fivefold with an Amicon DC-2 hollow fiber dialyzer/concentrator (Amicon Corp., Scientific Sys. Div., Lexington, Mass.) with an HlOP10 cartridge. The concentrated supernate was then lyophilized. Glycosphingolipids were isolated from both the lyophilized urinary sediment and supernate according to the method described by Desnick et al. (7) . Glycosphingolipids were further purified by DEAE-cellulose chromatography according to Ledeen et al. (13) . Separation and quantitation of glycosphingolipids by thin-layer chromatography were performed according to the procedures described (14, 15) . Each glycosphingolipid was isolated in pure form by preparative thin-layer chromatography. Specific glycosidases were used to sequentially hydrolyze the saccharide units in the glycolipids (16) . Various glycosidase activities in leukocytes were assayed according to the procedure of Wenger et al. (17) . Urine from a patient with Fabry's disease was kindly provided by Dr. Robert Hurst, University of Alabama Medical Center, Birmingham, Alabama. Cases studied are presented in Table I . (Table I) and a persistent proteinuria, we investigated the urine from several patients with proteinuria. Fig. 2 shows the thin-layer chromatogram of glycosphingolipids isolated from the urinary sediment of cases 1-3. It can be noted that the urinary sediment from these patients demonstrated high levels of glycosphingolipids ineluding globoside, trihexosyleeramiidle, and lactosyleeramide. We further examinied the excretion patterns of glycosphiingolipids in urinary suipernate and urinary sediment of' cases 4-7. As showin in Fig. 3 , the 6,000 g supernate contained more glycosphingolipid from the 6,000 g sediment.
To determine if the glycosphingolipids found in the 6,000 g supernate are associated with membrane fragments, the 6,000 g supernate of' case 4 from the resulting 100,000 g supernate and sediment. As shown in Fig. 4 , the 100,000 g supernate still contains -=50% of the glycosphingolipids found in the 6,000 g supernate. The nature of the association of the "soluble"glycosphingolipids remains to be determined. 1, analysis of glycosphingolipids in urinary sediment and assay of specific glycosidases in the leukocytes were performed. Although glycosidase activities were within the normal range, the thin-layer chromatograms showed increasedl excretion of urinary glycosphingolipids; however, as shown in Fig. 1 , the glycosphingolipid pattern does not correspond to that reported in Fabry's disease. After the patient's death, we found that he did not have a glycosphingolipid storage dis- (Figs. 1-4) , the glycosphingolipid pattern does not resemble that of normal kidney (24, 25, 26) . Also, kidney is the only visceral organ which contains appreciable amounts of galactosylceramide in addition to glucosylceramide (24) . The ratio of glucosylceramide to galactosylceramide is reported to be 1:0.6 (24) . By using borate-impregnated thin-layer chromatography plates (27) , it was found in cases 4 and 6 that the ratio of glucosylceramide to galactosylceramide was -1:0.7. The results suggest that the monohexosylceramide is renal in origin; however, the source of the other three major glycosphingolipids is not known.
The results presented above demonstrate that abnormal neutral glycosphingolipid excretion occurs in all cases of proteinuria examined as well as in the lipid storage disorders. Furthermore, the 24 h excretion in some cases of proteinuiria is equal to that seen in lipidoses.
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